Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888820 · ClinicalTrials.gov registry record · Phase 4
Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain
A Phase 4 study of Chronic Low Back Pain, sponsored by Sport and Spine Rehab Clinical Research Foundation.
- Active
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03888820: Active Phase 4 study of Chronic Low Back Pain, sponsored by Sport and Spine Rehab Clinical Research Foundation.
NCT03888820 is a Phase 4 study of Chronic Low Back Pain that is active but no longer recruiting, run by Sport and Spine Rehab Clinical Research Foundation. The registered enrollment target is 20 participants, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03888820, a Phase 4 study of Chronic Low Back Pain, is active but no longer recruiting, sponsored by Sport and Spine Rehab Clinical Research Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the effect of Biofreeze® versus a placebo on walking gait characteristics and pain during walking in individuals with cLBP.
Primary Outcome
Pain will be measures on a scale of 0 to 10, 0 being no pain at all and 10 representing the worst imaginable pain.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Biofreeze
Study Locations (1)
Maryland
- Sport and Spine Rehab - Rockville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2019-04-30 |
| Phase | Phase 4 |
What the registry record for NCT03888820 still lists
NCT03888820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 592-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03888820 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT03888820 about?
NCT03888820 is a clinical study titled "Biofreeze® vs. a Placebo on Chronic Low Back Pain Walking Gait Characteristics and Pain". The purpose of this study is to determine the effect of Biofreeze® versus a placebo on walking gait characteristics and pain during walking in individuals with cLBP.
What is the current status of trial NCT03888820?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2018-03-01. Estimated completion is 2019-04-30.
What conditions does trial NCT03888820 study?
This clinical trial studies the following conditions: Chronic Low Back Pain.
What interventions are being tested in trial NCT03888820?
The interventions under investigation include: Placebo (DRUG), Biofreeze (DRUG).
Who is sponsoring clinical trial NCT03888820?
This trial is sponsored by Sport and Spine Rehab Clinical Research Foundation, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03888820 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Low Back Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03888820's enrollment target sits among peer trials
20 67th of 71 higher than 3 of 71 other Chronic Low Back Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Low Back Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Determining the Prognostic Value of Continuous Intrathecal Infusion
COMPLETED · Phase 4
-
Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain
COMPLETED · Phase 4
-
The Back Pain Consortium Research Program Study
COMPLETED · Phase 4
-
Mobile Neurofeedback for Low Back Pain
RECRUITING · NA
-
Phenotyping Response to Spinal Cord Stimulation in Chronic Low Back Pain
RECRUITING · NA
-
Active Music-Based Intervention in Patients With Chronic Low Back Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI